טוען...
Single dose oral sulindac for acute postoperative pain in adults
BACKGROUND: Sulindac is a non‐steroidal anti‐inflammatory drug (NSAID) licensed for use in rheumatic disease and other musculoskeletal disorders in the UK, and widely available in other countries worldwide. This review sought to evaluate the efficacy and safety of oral sulindac in acute postoperativ...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2009
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4170893/ https://ncbi.nlm.nih.gov/pubmed/19821425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007540.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|